Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

The API2-MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling.

Rosebeck S, Rehman AO, Apel IJ, Kohrt D, Appert A, O'Donnell MA, Ting AT, Du MQ, Baens M, Lucas PC, McAllister-Lucas LM.

Oncogene. 2014 May 8;33(19):2520-30. doi: 10.1038/onc.2013.195. Epub 2013 Jun 17.

PMID:
23770847
[PubMed - indexed for MEDLINE]
2.

A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions.

Noels H, van Loo G, Hagens S, Broeckx V, Beyaert R, Marynen P, Baens M.

J Biol Chem. 2007 Apr 6;282(14):10180-9. Epub 2007 Feb 7.

PMID:
17287209
[PubMed - indexed for MEDLINE]
Free Article
3.

A dual role for the API2 moiety in API2-MALT1-dependent NF-kappaB activation: heterotypic oligomerization and TRAF2 recruitment.

Lucas PC, Kuffa P, Gu S, Kohrt D, Kim DS, Siu K, Jin X, Swenson J, McAllister-Lucas LM.

Oncogene. 2007 Aug 16;26(38):5643-54. Epub 2007 Mar 5.

PMID:
17334391
[PubMed - indexed for MEDLINE]
4.

Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.

Hosokawa Y.

Apoptosis. 2005 Jan;10(1):25-34. Review.

PMID:
15711920
[PubMed - indexed for MEDLINE]
5.

Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma development and treatment.

Rosebeck S, Lucas PC, McAllister-Lucas LM.

Future Oncol. 2011 May;7(5):613-7. doi: 10.2217/fon.11.35. Review.

PMID:
21568677
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.

Ho L, Davis RE, Conne B, Chappuis R, Berczy M, Mhawech P, Staudt LM, Schwaller J.

Blood. 2005 Apr 1;105(7):2891-9. Epub 2004 Dec 14.

PMID:
15598810
[PubMed - indexed for MEDLINE]
Free Article
7.

Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein.

Nakagawa M, Seto M, Hosokawa Y.

Leukemia. 2006 Jun;20(6):929-36. Review.

PMID:
16572204
[PubMed - indexed for MEDLINE]
8.

Activation of NF-kappaB and inhibition of p53-mediated apoptosis by API2/mucosa-associated lymphoid tissue 1 fusions promote oncogenesis.

Stoffel A, Chaurushiya M, Singh B, Levine AJ.

Proc Natl Acad Sci U S A. 2004 Jun 15;101(24):9079-84. Epub 2004 Jun 7.

PMID:
15184680
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination.

Baens M, Fevery S, Sagaert X, Noels H, Hagens S, Broeckx V, Billiau AD, De Wolf-Peeters C, Marynen P.

Cancer Res. 2006 May 15;66(10):5270-7.

PMID:
16707452
[PubMed - indexed for MEDLINE]
Free Article
10.

Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation.

Rosebeck S, Madden L, Jin X, Gu S, Apel IJ, Appert A, Hamoudi RA, Noels H, Sagaert X, Van Loo P, Baens M, Du MQ, Lucas PC, McAllister-Lucas LM.

Science. 2011 Jan 28;331(6016):468-72. doi: 10.1126/science.1198946. Erratum in: Science. 2011 Apr 22;332(6028):421.

PMID:
21273489
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Antiapoptotic function of apoptosis inhibitor 2-MALT1 fusion protein involved in t(11;18)(q21;q21) mucosa-associated lymphoid tissue lymphoma.

Hosokawa Y, Suzuki H, Suzuki Y, Takahashi R, Seto M.

Cancer Res. 2004 May 15;64(10):3452-7.

PMID:
15150097
[PubMed - indexed for MEDLINE]
Free Article
12.

Stability and subcellular localization of API2-MALT1 chimeric protein involved in t(11;18) (q21;q21) MALT lymphoma.

Izumiyama K, Nakagawa M, Yonezumi M, Kasugai Y, Suzuki R, Suzuki H, Tsuzuki S, Hosokawa Y, Asaka M, Seto M.

Oncogene. 2003 Nov 6;22(50):8085-92.

PMID:
14603249
[PubMed - indexed for MEDLINE]
13.

Auto-ubiquitination-induced degradation of MALT1-API2 prevents BCL10 destabilization in t(11;18)(q21;q21)-positive MALT lymphoma.

Noels H, Somers R, Liu H, Ye H, Du MQ, De Wolf-Peeters C, Marynen P, Baens M.

PLoS One. 2009;4(3):e4822. doi: 10.1371/journal.pone.0004822. Epub 2009 Mar 12.

PMID:
19279678
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway.

Lucas PC, Yonezumi M, Inohara N, McAllister-Lucas LM, Abazeed ME, Chen FF, Yamaoka S, Seto M, Nunez G.

J Biol Chem. 2001 Jun 1;276(22):19012-9. Epub 2001 Mar 21.

PMID:
11262391
[PubMed - indexed for MEDLINE]
Free Article
15.

TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.

Garrison JB, Samuel T, Reed JC.

Oncogene. 2009 Apr 2;28(13):1584-93. doi: 10.1038/onc.2009.17. Epub 2009 Feb 23.

PMID:
19234489
[PubMed - indexed for MEDLINE]
16.
17.

Nuclear factor kappaB activation and antiapoptosis in mucosa-associated lymphoid tissue lymphoma.

Hosokawa Y, Seto M.

Int J Hematol. 2004 Oct;80(3):215-23. Review.

PMID:
15540895
[PubMed - indexed for MEDLINE]
18.

Y14 positively regulates TNF-α-induced NF-κB transcriptional activity via interacting RIP1 and TRADD beyond an exon junction complex protein.

Togi S, Shiga K, Muromoto R, Kato M, Souma Y, Sekine Y, Kon S, Oritani K, Matsuda T.

J Immunol. 2013 Aug 1;191(3):1436-44. doi: 10.4049/jimmunol.1300501. Epub 2013 Jul 1.

PMID:
23817415
[PubMed - indexed for MEDLINE]
19.

Actvation of NF-kappaB by the API2/MALT1 fusions inhibits p53 dependant but not FAS induced apoptosis: a directional link between NF-kappaB and p53.

Stoffel A, Levine AJ.

Cell Cycle. 2004 Aug;3(8):1017-20. Epub 2004 Aug 25. Review.

PMID:
15280657
[PubMed - indexed for MEDLINE]
Free Article
20.

API2-MALT1 fusion gene in colorectal lymphoma.

Sakugawa ST, Yoshino T, Nakamura S, Inagaki H, Sadahira Y, Nakamine H, Okabe M, Ichimura K, Tanimoto M, Akagi T.

Mod Pathol. 2003 Dec;16(12):1232-41.

PMID:
14681324
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk